Results
|
|
1401.
|
Safety of immune checkpoint inhibitors in Chinese patients with melanoma. [electronic resource] by
- Wen, Xizhi
- Wang, Yao
- Ding, Ya
- Li, Dandan
- Li, Jingjing
- Guo, Yiqun
- Peng, Ruiqing
- Zhao, Jingjing
- Zhang, Xing
- Zhang, Xiao-Shi
Producer: 20180117
In:
Melanoma research vol. 26
Availability: No items available.
|
|
|
1402.
|
A Phase I Study of the Combination of Rituximab and Ipilimumab in Patients with Relapsed/Refractory B-Cell Lymphoma. [electronic resource] by
- Tuscano, Joseph M
- Maverakis, Emanual
- Groshen, Susan
- Tsao-Wei, Denice
- Luxardi, Guillaume
- Merleev, Alexander A
- Beaven, Anne
- DiPersio, John F
- Popplewell, Leslie
- Chen, Robert
- Kirschbaum, Mark
- Schroeder, Mark A
- Newman, Edward M
Producer: 20200921
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 25
Availability: No items available.
|
|
|
1403.
|
CTLA-4 blockade with ipilimumab induces significant clinical benefit in a female with melanoma metastases to the CNS. [electronic resource] by
- Hodi, F Stephen
- Oble, Darryl A
- Drappatz, Jan
- Velazquez, Elsa F
- Ramaiya, Nikhil
- Ramakrishna, Naren
- Day, Arthur L
- Kruse, Andrea
- Mac Rae, Suzanne
- Hoos, Axel
- Mihm, Martin
Producer: 20081209
In:
Nature clinical practice. Oncology vol. 5
Availability: No items available.
|
|
|
1404.
|
|
|
|
1405.
|
|
|
|
1406.
|
|
|
|
1407.
|
Experience in daily practice with ipilimumab for the treatment of patients with metastatic melanoma: an early increase in lymphocyte and eosinophil counts is associated with improved survival. [electronic resource] by
- Delyon, J
- Mateus, C
- Lefeuvre, D
- Lanoy, E
- Zitvogel, L
- Chaput, N
- Roy, S
- Eggermont, A M M
- Routier, E
- Robert, C
Producer: 20131118
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 24
Availability: No items available.
|
|
|
1408.
|
|
|
|
1409.
|
|
|
|
1410.
|
|
|
|
1411.
|
|
|
|
1412.
|
Immune Activation in Early-Stage Non-Small Cell Lung Cancer Patients Receiving Neoadjuvant Chemotherapy Plus Ipilimumab. [electronic resource] by
- Yi, John S
- Ready, Neal
- Healy, Patrick
- Dumbauld, Chelsae
- Osborne, Robyn
- Berry, Mark
- Shoemaker, Debra
- Clarke, Jeffrey
- Crawford, Jeffrey
- Tong, Betty
- Harpole, David
- D'Amico, Thomas A
- McSherry, Frances
- Dunphy, Frank
- McCall, Shannon J
- Christensen, Jared D
- Wang, Xiaofei
- Weinhold, Kent J
Producer: 20180801
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 23
Availability: No items available.
|
|
|
1413.
|
|
|
|
1414.
|
|
|
|
1415.
|
|
|
|
1416.
|
Immune checkpoint inhibitors as a bridge to allogeneic transplantation with posttransplant cyclophosphamide. [electronic resource] by
- Schoch, Laura K
- Cooke, Kenneth R
- Wagner-Johnston, Nina D
- Gojo, Ivana
- Swinnen, Lode J
- Imus, Philip
- Fuchs, Ephraim J
- Levis, Mark
- Ambinder, Richard F
- Jones, Richard J
- Gladstone, Douglas E
Producer: 20190828
In:
Blood advances vol. 2
Availability: No items available.
|
|
|
1417.
|
Structural basis for cancer immunotherapy by the first-in-class checkpoint inhibitor ipilimumab. [electronic resource] by
- Ramagopal, Udupi A
- Liu, Weifeng
- Garrett-Thomson, Sarah C
- Bonanno, Jeffrey B
- Yan, Qingrong
- Srinivasan, Mohan
- Wong, Susan C
- Bell, Alasdair
- Mankikar, Shilpa
- Rangan, Vangipuram S
- Deshpande, Shrikant
- Korman, Alan J
- Almo, Steven C
Producer: 20180503
In:
Proceedings of the National Academy of Sciences of the United States of America vol. 114
Availability: No items available.
|
|
|
1418.
|
|
|
|
1419.
|
Third-line pembrolizumab-induced immune-related interstitial pneumonitis after ipilimumab and nivolumab failure. [electronic resource] by
- Oya, Kazumasa
- Nakamura, Yoshiyuki
- Fujisawa, Yasuhiro
- Endo, Ruriko
- Tanaka, Ryota
- Ishitsuka, Yosuke
- Maruyama, Hiroshi
- Watanabe, Rei
- Okiyama, Naoko
- Fujimoto, Manabu
Producer: 20190219
In:
European journal of dermatology : EJD vol. 28
Availability: No items available.
|
|
|
1420.
|
|